DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Kilitch Drugs (India) Limited — Board Meeting Intimation

NSE 3 hrs ago·10 Aug 2026, 5:13 am

Kilitch Drugs (India)

Kilitch Drugs (India) Limited has announced that its board will meet on August 13, 2026, to review and approve the company's unaudited financial results for the quarter ending June 2026. This is a standard procedural update where the board typically reviews the company's performance before the results are officially disclosed to the public.

For investors, this meeting is a key calendar event as it signals the impending release of quarterly earnings. The results will provide fresh data on the company's revenue, profitability, and operational efficiency, which are critical factors for assessing its current financial health and future growth trajectory.

Investors should watch for the official release of these results to see if the company met or exceeded market expectations. Any significant deviation from forecasts could impact the stock's short-term price movement.